Much of the current interest in genetics stems from the Human Genome Project.
Although the project will accelerate the identification of disease-related genes, as currently formulated it may retard discovery of gene function and effective treatments, thereby prolonging the stage in which people at risk of genetic diseases can be identified but not treated.
This stage is fraught with ethical problems.
The project's goal of sequencing the entire human genome could also detract from basic biological research, as could the growing interest of universities in biotechnology transfer to the commercial sector.
Mots-clés Pascal : Maladie héréditaire, Dépistage, Technique, Génie génétique, Application médicale, Transfert technologie, Commercialisation, Organisation génome, Homme
Mots-clés Pascal anglais : Genetic disease, Medical screening, Technique, Genetic engineering, Medical application, Technology transfer, Marketing, Genome organization, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0094342
Code Inist : 002B23A. Création : 09/06/1995.